Bone Marrow Failure Syndromes Completed Phase 2 Trials for Busulfan (DB01008)

Also known as: Bone Marrow Failure Syndrome / Bone Marrow Failure Disorders

IndicationStatusPhase
DBCOND0035172 (Bone Marrow Failure Syndromes)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02349906Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant DiseasesTreatment